This clinical trial investigates the feasibility and safety of a portable exoskeleton device to improve mobility in patients with Parkinson's disease (PD). The study is sponsored by the VA Office of Research and Development, reflecting the significant burden of movement disorders among Veterans and the Department's commitment to developing innovative rehabilitation technologies["@nct"][@vaoffices].
...
Overview
Mermaid diagram (expand to render)
This clinical trial investigates the feasibility and safety of a portable exoskeleton device to improve mobility in patients with Parkinson's disease (PD). The study is sponsored by the VA Office of Research and Development, reflecting the significant burden of movement disorders among Veterans and the Department's commitment to developing innovative rehabilitation technologies["@nct"][@vaoffices].
Portable exoskeletons represent a promising frontier in [neurorehabilitation](/therapeutics/neurorehabilitation-neurodegeneration) for neurodegenerative diseases, offering device-based assistance that can be used in daily life settings rather than limited to clinical environments.
Trial Details
| Parameter | Value | |-----------|-------| | NCT Number | NCT06028529 | | Title | Portable Exoskeleton for Parkinson's Disease Mobility | | Status | Not Yet Recruiting / Recruiting | | Phase | Not Applicable (Feasibility Study) | | Sponsor | VA Office of Research and Development | | Mechanism | Device-based rehabilitation | | Intervention | Portable exoskeleton device | | Estimated Enrollment | Variable (typical feasibility: 20-50 participants) | | Study Design | Single-group or randomized controlled trial |
Conditions Studied
The trial targets patients with:
Idiopathic Parkinson's disease (PD)
Parkinsonian syndromes with mobility impairments
Gait dysfunction secondary to dopaminergic neurodegeneration
Mechanism of Action
Exoskeleton-Assisted Rehabilitation
Portable exoskeletons for Parkinson's disease operate through several mechanisms to improve mobility:
Mechanical Assistance — The device provides external torque to assist leg movements during walking, helping overcome bradykinesia and rigidity
Postural Support — Lightweight frames assist with balance and postural stability
Gait Normalization — Robotic guidance promotes more normal walking patterns
Sensory Feedback — Some devices provide proprioceptive cues that may help with movement initiation
[Dopaminergic neuron loss](/neurons/dopaminergic-neurons) in the [substantia nigra pars compacta](/brain-regions/substantia-nigra)
[Basal ganglia](/brain-regions/basal-ganglia) circuitry disruption affecting motor initiation
Bradykinesia — Slowness of movement that makes walking difficult
Freezing of gait — Sudden inability to initiate movement
Postural instability — Balance difficulties increasing fall risk
Traditional dopaminergic medications ([levodopa](/therapeutics/levodopa), [dopamine agonists](/therapeutics/dopamine-agonists)) effectively treat resting tremor and bradykinesia but often incompletely address gait dysfunction and freezing of gait. Exoskeletons offer a complementary mechanical approach.